Moderna, Inc. (MRNA) Operating margin 2016–2025
Moderna, Inc. (MRNA) operating margin by fiscal year — reported operating income divided by reported revenue.
-158.1%FY2025 · since FY2016: -206.4% → -158.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -158.1% | -36.2 pp |
| FY2024 | -121.9% | -60.0 pp |
| FY2023 | -61.9% | -110.8 pp |
| FY2022 | 48.9% | -23.1 pp |
| FY2021 | 72.0% | +167.0 pp |
| FY2020 | -95.0% | +811.8 pp |
| FY2019 | -906.8% | -600.9 pp |
| FY2018 | -306.0% | -175.1 pp |
| FY2017 | -130.9% | +75.6 pp |
| FY2016 | -206.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice